Wireless Medical Devices: Experts Explore Patent and Regulatory Issues
ARLINGTON, Va., Jan. 25, 2012 /PRNewswire-USNewswire/ -- Offering immense convenience for patients and doctors alike, bringing together wireless technology and software in the medical device arena also raises intricate patent and regulatory issues. It is clear however, that with the multi-billion dollar wireless medical device industry growing at a rapid pace, standards are needed to guide companies as they file for patents for these devices, as well as related necessary software.
(Logo: http://photos.prnewswire.com/prnh/20120110/DC33627LOGO )
Join us on January 26 for Bloomberg BNA's webinar, The Future of Wireless Medical Devices, as experts discuss how both large and small companies can meet the requirements of the FCC and FDA as well as the pitfalls that can occur when filing patent applications for novel wireless medical devices.
This 90-minute presentation will cover FCC regulation of licensed and unlicensed wireless medical devices; current and proposed rules for wireless medical device use in the U.S. and internationally; the FDA's key concerns regarding wireless technologies; software as a regulated medical device; provisional patent applications with the USPTO; methods of treatment or diagnosis; and joint research and development for wireless medical technologies.
Register now for this program get expert insight on:
• FCC regulation of licensed and unlicensed wireless medical devices
• FDA's key concerns regarding wireless technologies
• Provisional patent applications with the USPTO
• Joint research and development for wireless medical technologies
About the Speakers
Keith A. Barritt is a Principal in the Washington, D.C. office of Fish & Richardson P.C. His practice is focused on all aspects of medical device regulation by the U.S. Food and Drug Administration, including obtaining marketing authorization for medical devices, use of new devices for investigational purposes, and import and export issues. Mr. Barritt has prepared and filed 510(k) pre-market notifications with the FDA for various types of medical devices, resulting in the clearance of the devices for marketing. He has also advised clients on issues involving quality system regulations, device labeling, medical device reporting obligations, recalls, device listing, establishment registration, and import/export regulations. Mr. Barritt earned a J.D. from the University of Virginia and a B.A., cum laude, from the University of Virginia.
Bill Hunter is a Principal in the Southern California office of Fish & Richardson P.C. His practice emphasizes patent prosecution and counseling, patent strategy and analysis, development and management of patent portfolios, patent opinions, and due diligence investigations in connection with investments, mergers and acquisitions. Mr. Hunter has significant experience in advising individuals, start-up companies, universities and research institutes, and technology and manufacturing companies, particularly assisting clients with issues involving devices and software in medical diagnosis and treatment. Mr. Hunter earned a J.D., cum laude, from the University of California, Hastings College of the Law, and a B.S. from the University of California, San Diego.
Terry G. Mahn is Managing Principal of Fish & Richardson's Washington, D.C. office, and the Regulatory and Government Affairs Practice Group Leader. His practice is primarily before the FCC and FDA with emphasis on complex product authorizations. Mr. Mahn's FCC practice includes all facets of spectrum allocation, wireless technology and licensing, and equipment approvals. He actively participates in domestic and international product standards development, harmonization, and compliance in the areas of radio communications, EMC, electrical, medical, and RF safety. Mr. Mahn earned a J.D. from Catholic University of America, Columbus School of Law, and a B.S. from the University of Michigan.
About Bloomberg BNA Legal & Business Webinars
Bloomberg BNA's Legal & Business Webinars are designed for today's busy professionals. In just 90 minutes, you have access to in-depth coverage of an ever-changing array of current topics, including the latest trends and developments, new and revised laws and regulations, and legal principles and precedent. Get expert insights into compliance requirements, as well as authoritative and practical guidance on the issues that matter most to you and your clients.
With our webinar topics covering the broad spectrum of legal practice areas and corporate issues, from Intellectual Property to Privacy to Pensions & Benefits, you can count on Bloomberg BNA to bring you quality content on today's hottest topics. What's more, Bloomberg BNA's Legal & Business webinars are CLE eligible, making it easy to stay compliant with your continuing education needs.
About Bloomberg BNA
Bloomberg BNA, a wholly-owned subsidiary of Bloomberg is a leading source of legal, regulatory, and business information for professionals. Its network of more than 2,500 reporters, correspondents, and leading practitioners delivers expert analysis, news, practice tools, and guidance - the information that matters most to professionals. Bloomberg BNA's authoritative coverage spans the full range of legal practice areas, including tax & accounting, labor & employment, intellectual property, banking & securities, employee benefits, health care, privacy & security, human resources, and environment, health & safety. www.bna.com
SOURCE Bloomberg BNA
Share this article